Cargando…

Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin

[Image: see text] Flavonoids are natural polyphenolic compounds with myriad biological activities and potential as prophylactic and therapeutic agents. However, poor aqueous solubility and low bioavailability have limited the clinical utility of flavonoids, suggesting that drug delivery systems (DDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sims, Kenneth R., He, Brian, Koo, Hyun, Benoit, Danielle S.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288370/
https://www.ncbi.nlm.nih.gov/pubmed/32548448
http://dx.doi.org/10.1021/acsomega.9b04101
_version_ 1783545262933803008
author Sims, Kenneth R.
He, Brian
Koo, Hyun
Benoit, Danielle S.W.
author_facet Sims, Kenneth R.
He, Brian
Koo, Hyun
Benoit, Danielle S.W.
author_sort Sims, Kenneth R.
collection PubMed
description [Image: see text] Flavonoids are natural polyphenolic compounds with myriad biological activities and potential as prophylactic and therapeutic agents. However, poor aqueous solubility and low bioavailability have limited the clinical utility of flavonoids, suggesting that drug delivery systems (DDSs) may improve their clinical relevance. Therefore, loading of a representative flavonoid (i.e., myricetin) into a diblock, polymeric nanoparticle carrier (NPC) DDS with a cationic corona and hydrophobic core was investigated. Absorbance and fluorescence spectroscopy results revealed association constants and standard Gibbs free energy values that align with previously reported values (K(a) = ∼1–3 × 10(4) M(–1); ΔG° = −5.4 to −6.0 kcal mol(–1)), suggesting that NPCs load myricetin via electrostatic interactions. The zeta potential and gel electrophoresis analysis confirmed this loading mechanism and indicated that NPCs improve myricetin solubility >25-fold compared to myricetin alone. Finally, the dual-drug loading of NPCs was tested using a combination of myricetin and a hydrophobic drug (i.e., farnesol). Electrostatic loading of NPCs with myricetin at concentrations ≤1.2 mM did not affect NPC core loading and release of farnesol, thus demonstrating a novel formulation strategy for the dual-drug-loaded NPC. These findings offer key insights into the NPC DDS design that may enhance the clinical relevance of flavonoid-based therapeutic approaches.
format Online
Article
Text
id pubmed-7288370
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-72883702020-06-15 Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin Sims, Kenneth R. He, Brian Koo, Hyun Benoit, Danielle S.W. ACS Omega [Image: see text] Flavonoids are natural polyphenolic compounds with myriad biological activities and potential as prophylactic and therapeutic agents. However, poor aqueous solubility and low bioavailability have limited the clinical utility of flavonoids, suggesting that drug delivery systems (DDSs) may improve their clinical relevance. Therefore, loading of a representative flavonoid (i.e., myricetin) into a diblock, polymeric nanoparticle carrier (NPC) DDS with a cationic corona and hydrophobic core was investigated. Absorbance and fluorescence spectroscopy results revealed association constants and standard Gibbs free energy values that align with previously reported values (K(a) = ∼1–3 × 10(4) M(–1); ΔG° = −5.4 to −6.0 kcal mol(–1)), suggesting that NPCs load myricetin via electrostatic interactions. The zeta potential and gel electrophoresis analysis confirmed this loading mechanism and indicated that NPCs improve myricetin solubility >25-fold compared to myricetin alone. Finally, the dual-drug loading of NPCs was tested using a combination of myricetin and a hydrophobic drug (i.e., farnesol). Electrostatic loading of NPCs with myricetin at concentrations ≤1.2 mM did not affect NPC core loading and release of farnesol, thus demonstrating a novel formulation strategy for the dual-drug-loaded NPC. These findings offer key insights into the NPC DDS design that may enhance the clinical relevance of flavonoid-based therapeutic approaches. American Chemical Society 2020-05-28 /pmc/articles/PMC7288370/ /pubmed/32548448 http://dx.doi.org/10.1021/acsomega.9b04101 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Sims, Kenneth R.
He, Brian
Koo, Hyun
Benoit, Danielle S.W.
Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin
title Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin
title_full Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin
title_fullStr Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin
title_full_unstemmed Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin
title_short Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin
title_sort electrostatic interactions enable nanoparticle delivery of the flavonoid myricetin
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288370/
https://www.ncbi.nlm.nih.gov/pubmed/32548448
http://dx.doi.org/10.1021/acsomega.9b04101
work_keys_str_mv AT simskennethr electrostaticinteractionsenablenanoparticledeliveryoftheflavonoidmyricetin
AT hebrian electrostaticinteractionsenablenanoparticledeliveryoftheflavonoidmyricetin
AT koohyun electrostaticinteractionsenablenanoparticledeliveryoftheflavonoidmyricetin
AT benoitdaniellesw electrostaticinteractionsenablenanoparticledeliveryoftheflavonoidmyricetin